# NHS Framework Agreement for the supply of Medical Retinal Vascular Treatments

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Tender value: £450,000
- Published: 7 March 2022
- Planned start: 1 June 2022
- Planned end: 31 May 2023
- Stage: open_tender
- Procurement category: goods
- Notice ID: 8a741f2e-50b2-4db2-899e-bd3ddad50453-516007
- OCID: ocds-b5fd17-e97776f4-2d6d-4c30-86d2-a440d3929e28

## Description

The Procurement relates to the supply of medical retinal vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England\. Period of framework: 1 June 2022 to 31 May 2023 with an option to extend \(at the Authority's discretion\) for a further period \(or periods\) up to a total of 12 months \(i\.e\. total possible framework duration of 24 months\) http://health\.atamis\.co\.uk/

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/8a741f2e-50b2-4db2-899e-bd3ddad50453-516007)